Header Image


As an American biotechnology corporation operating and serving patients globally, MedTherapy Biotech works with the investor community worldwide. We welcome mutually productive partnership with financial institutions from all over the globe. We have existing partnership with institutions from all sectors – private, public, academic and charitable world.

Top 10 advantages that MedTherapy Biotech has for commercial success  in the dynamic world of cancer cell and gene therapy:

  • Founded by the leading experts on cancer gene therapy from Harvard University and former Novartis experts;
  • Full-service, end-to-end, integrated, CAR-T cell gene therapy biotech Global manufacturing facilities;
  • Partnership with global experts in cell, gene and immunotherapies from prestigious private and public institutions from US, Europe and Asia;
  • In-house global scale GMP manufacturing facilities, and, in-house large scale virus vector manufacturing facilities
  • Proprietary manufacturing processes and platform for cell, gene and immunotherapies;
  • Among the best in the world:
      • One of the most advanced, brand new, state of art futuristic 21stcentury manufacturing facilities for cell, gene and immunotherapies;
      • One of the shortest manufacturing time for CAR-T cell therapies;
      • One of the shortest time from investment to revenue;
      • One of the most de-risked CAR-T cell therapy biotech companies due to parallel strategies;
  • Not predicated upon the vagaries of unpredictable and unsuccessful clinical trials;
  • One of the most cost-effective manufacturers in the world for cell, gene and immunotherapies;
  • Globally renowned lead investor;
  • Business model with one of the highest and fastest Return on Investment (ROI).

Contact us at: Info@MedTherapyBiotech.Com